Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Iron Versus Ferrous Iron Supplementation for Early Prophylaxis of Iron Deficiency Anemia in Preterm Neonates
NCT07667205Phase 1Enrolling by invitation
- Sponsor
- Ain Shams University
- Start
- Jul 2025
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ferric pyrophosphate liposomal in iron deficiency anemia (IDA) (3 arms), sponsored by Ain Shams University. Primary endpoints: Hemoglobin concentration at 3 months, Serum ferritin level at 3 months and 4 more. Started Jul 2025; status: enrolling by invitation.
02
Drugs
ferric pyrophosphate liposomal
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07667205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07667205.